The Service of the Commission for the Protection of Competition on the 10th of November 2008 received on behalf of the company Ivytan AB notification of a proposed concentration according to Article 13 of the Control of Concentration between Enterprises Law (Number 22(I)/99), concerning an agreement by which Ivytan AB will proceed to a public offer in order to acquire 100% of the issued share capital of the company Q-Med AB.
” Ivytan AB” is a new enterprises whose only aim to acquire all of Q-Med AB´s share capital.
“Q-Med AB” operations concentrate in the medical sector with the development, construction and sale of implants και other goods to be used in hospitals.
|